This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Biolegend, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Anagha Ashok Divekar: Innovator in Anti-TLR9 Agents
Introduction
Anagha Ashok Divekar is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-TLR9 agents. His innovative work has led to the creation of valuable compositions and methods that have potential applications in diagnostics and therapeutics.
Latest Patents
Anagha holds 1 patent for his invention titled "Anti-TLR9 agents and compositions and methods for making and using the same." This patent describes compositions and methods for creating and utilizing anti-TLR9 agents, including monoclonal antibodies and TLR9-binding antibody fragments. The patent also covers diagnostic reagents and kits that incorporate these agents, showcasing the practical applications of his research.
Career Highlights
Anagha is currently employed at BioLegend, Inc., a company known for its commitment to advancing research in the life sciences. His work at BioLegend has allowed him to focus on innovative solutions that address critical challenges in immunology and related fields.
Collaborations
Anagha has collaborated with talented individuals such as Nicole Vivienne Acuff and Takatoku Oida. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking technologies.
Conclusion
Anagha Ashok Divekar is a distinguished inventor whose work in anti-TLR9 agents exemplifies the intersection of innovation and biotechnology. His contributions continue to impact the scientific community and pave the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile